Table 4.
Phase-contrast velocity mapping-based parameters
Controls (n = 7) | DOCA (n = 5) | Controls vs. DOCA | ||||||
---|---|---|---|---|---|---|---|---|
Parameter | Rest | Stress | p | Rest | Stress | p | prest | pstress |
Aortic vessel wall and aortic blood velocity | ||||||||
APV (cm · s−1) | 113 ± 15 | 158 ± 26 | 0.001 | 92 ± 14 | 140 ± 31 | 0.011 | 0.033 | 0.308 |
AAmean (mm−2) | 3.4 ± 0.4 | 3.7 ± 0.7 | 0.091 | 5.5 ± 0.5 | 5.0 ± 1.3 | 0.244 | < 0.001 | 0.064 |
AAmin (mm−2) | 2.8 ± 0.4 | 3.0 ± 0.6 | 0.211 | 4.6 ± 0.5 | 4.2 ± 1.1 | 0.229 | < 0.001 | 0.044 |
AAmax (mm−2) | 4.1 ± 0.4 | 4.5 ± 0.6 | 0.061 | 6.3 ± 0.5 | 5.7 ± 1.4 | 0.228 | < 0.001 | 0.072 |
AWT (mm) | 1.8 ± 0.3 | 2.3 ± 0.4 | 0.039 | |||||
Transmitral and myocardial tissue velocities | ||||||||
E (cm · s−1) | 63 ± 6 | 78 ± 9 | 0.001 | 56 ± 10 | 70 ± 11 | 0.001 | 0.181 | 0.222 |
A (cm · s−1) | 47 ± 11 | 48 ± 9 | 0.714 | 43 ± 12 | 43 ± 13 | 0.801 | 0.532 | 0.404 |
E/A | 1.4 ± 0.5 | 1.7 ± 0.5 | 0.100 | 1.4 ± 0.4 | 1.7 ± 0.5 | < 0.001 | 0.861 | 0.886 |
AT (ms) | 87 ± 17 | 79 ± 9 | 0.329 | 83 ± 14 | 70 ± 9 | 0.091 | 0.639 | 0.120 |
DT (ms) | 152 ± 50 | 163 ± 66 | 0.705 | 169 ± 67 | 153 ± 16 | 0.639 | 0.622 | 0.760 |
E’sep (cm · s−1) | 18 ± 4 | 20 ± 6 | 0.743 | 11 ± 3 | 14 ± 2 | 0.109 | 0.010 | 0.069 |
E’lat (cm · s−1) | 21 ± 5 | 25 ± 6 | 0.346 | 14 ± 3 | 16 ± 3 | 0.213 | 0.067 | 0.019 |
E’ (cm · s−1) | 20 ± 4 | 23 ± 6 | 0.492 | 13 ± 2 | 15 ± 2 | 0.130 | 0.007 | 0.025 |
E/E’ | 3.3 ± 0.6 | 3.6 ± 0.7 | 0.185 | 4.4 ± 1.1 | 4.6 ± 0.6 | 0.707 | 0.038 | 0.031 |
(E/E’)/EDV (10−2 ml−1 · m2) | 2.7 ± 0.5 | 3.1 ± 0.6 | 0.151 | 3.6 ± 0.9 | 4.8 ± 1.6 | 0.112 | 0.035 | 0.030 |
Pulmonary venous velocities | ||||||||
S1 (cm · s−1) | 33 ± 9 | 48 ± 4 | 0.006 | 39 ± 18 | 46 ± 5 | 0.516 | 0.502 | 0.408 |
S2 (cm · s−1) | 40 ± 10 | 49 ± 9 | 0.032 | 44 ± 18 | 44 ± 5 | 0.668 | 0.624 | 0.484 |
D (cm · s−1) | 37 ± 10 | 56 ± 11 | < 0.001 | 57 ± 17 | 58 ± 6 | 0.792 | 0.035 | 0.636 |
S/D | 1.1 ± 0.2 | 0.9 ± 0.2 | 0.019 | 0.8 ± 0.2 | 0.8 ± 0.2 | 0.864 | 0.045 | 0.194 |
Coronary sinus | ||||||||
NFVCS (ml · m−2) | 1.6 ± 0.5 | 2.7 ± 1.0 | 0.003 | 2.4 ± 0.6 | 2.8 ± 0.5 | 0.300 | 0.025 | 0.886 |
GMP (ml · min−1 · g−1) | 1.6 ± 0.4 | 3.7 ± 1.4 | 0.002 | 1.9 ± 0.3 | 2.9 ± 0.5 | 0.029 | 0.197 | 0.268 |
MPR | 2.2 ± 0.5 | 1.5 ± 0.4 | 0.028 |
APV aortic peak velocity, AA mean average aortic cross section area, AA min minimal aortic cross section area, AA max maximal aortic cross section area, AWT aortic wall thickness, E early diastolic transmitral peak velocity, A late diastolic transmitral peak velocity, E’ sept early diastolic septal wall mitral annular tissue velocity, E’ lat early diastolic lateral wall mitral annular tissue velocity, E’ average early diastolic mitral annular tissue velocity, S1 early systolic pulmonary venous peak velocity, S2 systolic pulmonary venous peak velocity, D early diastolic pulmonary venous peak velocity, S maximal systolic pulmonary venous peak velocity, NFV CS coronary sinus net forward volume, GMP global myocardial perfusion, MPR stress-to-rest myocardial perfusion reserve
p is related to the rest-stress comparison within each group. prest and pstress relate to group comparisons at rest and stress, respectively